Insider Selling: Omnicell CEO Unloads 64,453 Shares of Stock (OMCL)
Omnicell (NASDAQ:OMCL) CEO Randall Lipps unloaded 64,453 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, September 18th. The stock was sold at an average price of $23.67, for a total value of $1,525,602.51. Following the transaction, the chief executive officer now directly owns 202,362 shares in the company, valued at approximately $4,789,909. The sale was disclosed in a legal filing with the SEC, which is available at this link.
A number of analysts have recently weighed in on OMCL shares. Analysts at Zacks reiterated a “neutral” rating on shares of Omnicell (NASDAQ:OMCL) in a research note to investors on Wednesday, August 21st. They now have a $24.00 price target on the stock. Analysts at Cowen and Company raised their price target on shares of Omnicell (NASDAQ:OMCL) from $18.00 to $21.00 in a research note to investors on Friday, August 2nd. They now have a “market perform” rating on the stock.
Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $22.00.
Omnicell (NASDAQ:OMCL) traded up 3.54% during mid-day trading on Friday, hitting $24.87. The stock had a trading volume of 317,007 shares. Omnicell has a one year low of $12.61 and a one year high of $24.90. The stock has a 50-day moving average of $23.12 and a 200-day moving average of $19.98. The company has a market cap of $866.5 million and a P/E ratio of 38.13.
Omnicell (NASDAQ:OMCL) last posted its quarterly earnings results on Thursday, August 1st. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.02. The company had revenue of $93.70 million for the quarter, compared to the consensus estimate of $92.42 million. During the same quarter in the previous year, the company posted $0.20 earnings per share. The company’s revenue for the quarter was up 24.3% on a year-over-year basis. Analysts expect that Omnicell will post $1.05 EPS for the current fiscal year.
Omnicell, Inc (NASDAQ:OMCL) is a provider of automated solutions for hospital medication and supply management.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.